CTOs on the Move

Institute for Medical Research

www.imr.org

 
Institute for Medical Research is a Durham, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.imr.org
  • 508 Fulton St
    Durham, NC USA 27705
  • Phone: 919.286.0411

Executives

Name Title Contact Details

Similar Companies

Liberty Healthcare Management

Liberty Healthcare Management is a Ramsey, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Interior Health

With the help of our staff and physicians, Interior Health is proud to deliver high-quality health-care services to the communities and visitors of the Southern Interior of British Columbia. We strive to set new standards of excellence in the delivery of health services in the province of B.C. and our mission is to promote healthy lifestyles and provide needed health services in a timely, caring and efficient manner, to the highest professional and quality standards.

MDI Medical

MDI Medical is a Norcross, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

The Tech Group Subsidiary of West Pharmaceutical Services

The Tech Group, Inc Subsidiary of West Pharmaceutical Services, Inc. is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. The Tech Group, Inc Subsidiary of West Pharmaceutical Services, Inc. is based in Scottsdale, AZ. You can find more information on The Tech Group, Inc Subsidiary of West Pharmaceutical Services, Inc. at www.techgroup.com

Fractyl Laboratories

At Fractyl, we are focused on improving the health of people with Type 2 diabetes. We`ve created an innovative clinical procedure based on new insights into the root cause of the disease. We are currently engaged in clinical trials designed to prove that our innovative procedure can dramatically improve glucose control and reduce the need for additional medications. Our mission is to set people free from the daily burdens of Type 2 diabetes management, empower physicians with a safe and reliable therapeutic treatment, and lower the tremendous human and financial costs of diabetic complications for patients, hospitals, and payers.